-+ 0.00%
-+ 0.00%
-+ 0.00%

BRAINCHILD BIO: INITIATES PIVOTAL PHASE 2 TRIAL FOR BCB-276 CAR T CELL THERAPY FOR DIPG, A DEADLY PEDIATRIC BRAIN CANCER

Reuters·09/08/2026 11:07:05

Please log in to view news